Amanta Healthcare Limited IPO: Issue Price, Listing Gain and Share Price Now
Amanta Healthcare Limited listed on 09-Sep-2025 at ₹140.65 against an issue price of ₹126 , a listing gain of +11.63%. It last traded at ₹186.05. This page is the record of that issue and what has happened to it since — reported figures only.
Amanta Healthcare Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹126 |
| Listing price (listing-day close) | ₹140.65 |
| Listing gain | +11.63% |
| Price now | ₹186.05 |
| Change from issue price | +47.66% |
| Change from listing-day close | +32.28% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Amanta Healthcare Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹126 |
| Issue size | ₹126 Cr |
| Fresh issue | ₹126 Cr |
| Issue opened | 01-Sep-2025 |
| Issue closed | 03-Sep-2025 |
| Listed on | 09-Sep-2025 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Beeline Capital (left lead) |
How the Amanta Healthcare Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 35.86x |
| NII | 209.40x |
| Retail | 54.96x |
| Total | 82.60x |
Amanta Healthcare Limited today
| Figure | Value |
|---|---|
| Sector | Pharmaceuticals |
Fundamentals are as of the desk's last harvest and move with the market.
- Amanta Healthcare Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.